1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
657B304055F546FF46525844E00351850
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-improving-impact-cns-field-based-medical-teams-major-global-markets-thought-leader-engagement-managing-field-activities-productivity-levels?opendocument
18
19opendocument
203.94.202.88
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Science Liaison

Improving the Impact of CNS Field-Based Medical Teams in Major Global Markets: Thought Leader Engagement, Managing Field Activities & Productivity Levels

ID: 5571


Features:

8 Info Graphics

23 Data Graphics

270+ Metrics

5 Narratives


Pages/Slides: 37


Published: 2019


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Improving the Impact of CNS Field-Based Medical Teams in Major Global Markets: Thought Leader Engagement, Managing Field Activities & Productivity Levels”

STUDY OVERVIEW

Field-based medical teams play a vital role in meeting the growing information needs of key stakeholders and building effective thought leader relationships. As organizations seek to enhance their position in the central nervous system (CNS) market in the U.S. and expand their footprint in other high-potential global markets, it is critical to equip field-based medical teams with the tools and insights needed to effectively engage thought leaders and payers.


Best Practices, LLC undertook this benchmarking research to help companies fill knowledge gaps around key CNS MSL/field-based medical team operational areas, including: productivity measures, efficiency (time spent on key external and internal activities), frequency of thought leader interactions by tier, effective communication channels, and tactics and tools for leveraging field insights across the organization. This research will also help identify key deficiencies and opportunities for overcoming challenges that are present in medical affairs organizations of various regions, such as proactive vs. reactive interactions, meeting goal time for training and interactions, and measuring overall MSL value and effectiveness.

This research provides data in several segments: All Participants (Total Benchmark Class); Global (Outside US); North America Responses; and Europe Responses.

KEY TOPICS

  • Duration and frequency of MSL and HOL interactions
  • The degree of proactive vs. reactive interactions
  • Time spent on internal and external activities
  • Processes and tools used to leverage local field knowledge globally

KEY METRICS

  • What is your MSLs / HOLs average time spent in each face-to-face thought leader interaction / payer interaction?
  • How frequently do your MSLs interact with each kind of thought leader on average?
  • How frequently do your HOLs interact with payers on average?
  • What percentage of your MSLs’ thought leader interactions are proactive and what percentage are reactive?
  • How often do your field MSLs conduct the listed proactive and reactive activities?
  • How often do you file 2253 and send materials to OPDP (FDA) before starting to use a scientific piece?
  • Approximately how much time do your MSLs spend on average on the listed external and internal activities each week – and what is the ideal amount of time to be spent on each activity per week?
  • Which of the listed processes and tools are most effective for leveraging insights across the organization?

SAMPLE KEY FINDINGS

  • Effective tools used to leverage local field knowledge globally: Automating insight generation is being embraced equally by both the U.S. and European affiliates, though full automation appears challenging. Two-third of respondents in the U.S. and EU5 reported their insight analysis is fully automated. The ability to input, generate and access insights through some degree of automation could potentially aid MSLs in those markets perform other tasks more efficiently.


METHODOLOGY

Best Practices, LLC engaged 17 medical affairs and field-based medical team leaders working in CNS/neurology/pain management therapeutic area at 15 leading biopharma companies through a benchmarking survey. Six deep-dive interviews were conducted with medical affairs leaders, whose insights were provided to enrich the data and add real-world context to the metrics and trends established. To provide clear understanding of field medical trends across major markets, benchmark data is segmented by: Total Benchmark Class (N=17); Global Market Segment, excluding U.S. (N=9); North America Market Segment (N=8); and Europe (EU5) Market Segment (N=6).

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Chemical; Health Care; Medical Device


Companies Profiled:
AcelRx; Alkermes; Allergan; Amgen; Biogen; Chiesi; Daiichi Sankyo; Gedeon Richter ; Genentech; Janssen; Merck; Pfizer; Roche; Shire; Sunovion

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.